Skip Nav Destination
Close Modal
Update search
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-1 of 1
Keywords: Chemotherapy cycles
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Extended versus Standard Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Cohort Study
Available to PurchaseSubject Area:
Further Areas
Can Aydogdu, Florian Urban, Elena Berg, Melanie Götz, Severin Rodler, Isabel Brinkmann, Benazir Enzinger, Marie Semmler, Frederik Kolligs, Marina Hoffmann, Leo F. Stadelmeier, Thilo Westhofen, Lena M. Unterrainer, Volker Heinemann, Christian G. Stief, Alexander Tamalunas, Jozefina Casuscelli
Journal:
Urologia Internationalis
Urol Int (2026)
Published Online: 19 January 2026
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2026 Metastatic hormone-sensitive prostate cancer Docetaxel chemotherapy Androgen deprivation therapy Chemotherapy cycles Real-world evidence Addition of docetaxel...
